1. Home
  2. IVP vs BDRX Comparison

IVP vs BDRX Comparison

Compare IVP & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVP
  • BDRX
  • Stock Information
  • Founded
  • IVP 2020
  • BDRX 2000
  • Country
  • IVP United States
  • BDRX United Kingdom
  • Employees
  • IVP N/A
  • BDRX N/A
  • Industry
  • IVP Diversified Commercial Services
  • BDRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IVP Miscellaneous
  • BDRX Health Care
  • Exchange
  • IVP Nasdaq
  • BDRX Nasdaq
  • Market Cap
  • IVP 3.4M
  • BDRX 3.9M
  • IPO Year
  • IVP 2023
  • BDRX N/A
  • Fundamental
  • Price
  • IVP $0.98
  • BDRX $8.10
  • Analyst Decision
  • IVP
  • BDRX
  • Analyst Count
  • IVP 0
  • BDRX 0
  • Target Price
  • IVP N/A
  • BDRX N/A
  • AVG Volume (30 Days)
  • IVP 166.9K
  • BDRX 349.7K
  • Earning Date
  • IVP 11-12-2025
  • BDRX 09-23-2025
  • Dividend Yield
  • IVP N/A
  • BDRX N/A
  • EPS Growth
  • IVP N/A
  • BDRX N/A
  • EPS
  • IVP N/A
  • BDRX N/A
  • Revenue
  • IVP $15,292,904.00
  • BDRX N/A
  • Revenue This Year
  • IVP N/A
  • BDRX N/A
  • Revenue Next Year
  • IVP N/A
  • BDRX N/A
  • P/E Ratio
  • IVP N/A
  • BDRX N/A
  • Revenue Growth
  • IVP N/A
  • BDRX N/A
  • 52 Week Low
  • IVP $0.63
  • BDRX $5.00
  • 52 Week High
  • IVP $24.61
  • BDRX $108.90
  • Technical
  • Relative Strength Index (RSI)
  • IVP 52.35
  • BDRX 56.20
  • Support Level
  • IVP $0.93
  • BDRX $7.18
  • Resistance Level
  • IVP $1.00
  • BDRX $11.88
  • Average True Range (ATR)
  • IVP 0.07
  • BDRX 0.88
  • MACD
  • IVP -0.00
  • BDRX 0.15
  • Stochastic Oscillator
  • IVP 30.09
  • BDRX 30.33

About IVP Inspire Veterinary Partners Inc.

Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Share on Social Networks: